This story originally ran on Oct 26.

By Adam Bonislawski

Thermo Fisher Scientific this week reported a 13 percent rise in third-quarter revenue but lowered its full-year guidance, citing weakness in the academic and government markets, which account for roughly 23 percent to 24 percent of the company's revenues.

Revenues for the quarter were $2.97 billion compared to $2.63 billion from the year-ago period and missed analyst estimates of $3 billion.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.